C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability
- 1 October 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (2) , 474-477
- https://doi.org/10.1016/s0360-3016(01)01671-6
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- The Epidermal Growth Factor Receptor and Its Inhibition in Cancer TherapyPharmacology & Therapeutics, 1999
- The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate CarcinomaJournal of Immunotherapy, 1996
- Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal AntibodiesJNCI Journal of the National Cancer Institute, 1993